World's Best Scientists 2026 revealed!
Marc Schmitz

Marc Schmitz

D-Index & Metrics

Immunology

D-Index
64
Citations
11243
World Ranking
2970
National Ranking
198

Overview

Marc Schmitz is affiliated with TU Dresden in Germany and focuses on research within the fields of Medicine, Immunology, and Microbiology. Their work predominantly addresses oncology and immunology, with additional contributions in molecular biology, surgery, and genetics. The scientist's research extensively covers cancer immunotherapy, immune responses, and the role of immune cells in cancer.

The main topics in their research include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Pancreatic and Hepatic Oncology Research
  • Bladder and Urothelial Cancer Treatments

Marc Schmitz has published a significant number of papers, with notable recent contributions such as:

  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia, 2020, Science Translational Medicine
  • Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update, 2021, Frontiers in Cell and Developmental Biology
  • Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update, 2020, Journal of Clinical Medicine
  • Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer, 2021, Journal for ImmunoTherapy of Cancer
  • Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets, 2020, Frontiers in Immunology

Frequent co-authors collaborating with Marc Schmitz include:

  • Rebekka Wehner
  • Luise Rupp
  • Antje Tunger
  • Luise Müller
  • Michael Bachmann

Their research is regularly published in journals such as:

  • Frontiers in Immunology
  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Journal of Clinical Oncology

Best Publications

  • Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

    M von Bonin;F Stölzel;A Goedecke;K Richter

  • Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

    Marc Schmitz;Petra Diestelkoetter;Bernd Weigle;Florian Schmachtenberg

  • Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses

    Anja Hänsel;Claudia Günther;Jens Ingwersen;Josephine Starke

  • Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

    M Schmitz;A Temme;V Senner;R Ebner

  • Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders

    Senming Zhao;Rebekka Wehner;Martin Bornhäuser;Ralf Wassmuth

  • Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma

    Nadja Müller;Susanne Michen;Stefanie Tietze;Katrin Töpfer

  • Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

    Marc Cartellieri;Michael Bachmann;Anja Feldmann;Claudia Bippes

  • Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.

    Jacques Rohayem;Petra Diestelkoetter;Bernd Weigle;Antje Oehmichen

  • Enhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool

    S P Hehner;R Breitkreutz;G Shubinsky;H Unsoeld

  • Tumor evasion from T cell surveillance.

    Katrin Töpfer;Stefanie Kempe;Nadja Müller;Marc Schmitz

  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

    Jayakumar Vadakekolathu;Mark D. Minden;Tressa Hood;Sarah E. Church

  • Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier

    Kadriye Nehir Cosgun;Susann Rahmig;Nicole Mende;Sören Reinke

  • A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes

    K Schäkel;E Mayer;C Federle;M Schmitz

  • Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update.

    Luise Müller;Antje Tunger;Manja Wobus;Malte von Bonin;Malte von Bonin

  • The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells

    Rebekka Wehner;Kristin Dietze;Michael Bachmann;Marc Schmitz

  • Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.

    Ingo Drexler;Edite Antunes;Marc Schmitz;Thomas Wölfel

  • Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells

    Matthias Zeis;Sandra Siegel;Andreas Wagner;Marc Schmitz

  • Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial.

    Susanne Fuessel;Axel Meye;Marc Schmitz;Stefan Zastrow

  • Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma

    Christian Thiede;Thomas Wündisch;Birgit Alpen;Beatrix Neubauer

  • Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators

    Barbara Kaltschmidt;Christian Kaltschmidt;S.P. Hehner;W. Dröge

  • Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.

    Agnieszka Morgenroth;Marc Cartellieri;Marc Schmitz;Serap Günes

Frequent Co-Authors

Michael Bachmann
Michael Bachmann Helmholtz-Zentrum Dresden-Rossendorf
Anja Feldmann
Anja Feldmann Max Planck Society
Torsten Tonn
Torsten Tonn TU Dresden
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Jürgen Weitz
Jürgen Weitz TU Dresden
Sergio Rutella
Sergio Rutella Nottingham Trent University
Reinhard Ebner
Reinhard Ebner Human Genome Sciences (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Nursing is one of the closest allied fields, with various programs designed for different entry points and timelines. For individuals looking to advance quickly, programs like the easiest accelerated nursing programs offer a streamlined path to becoming a registered nurse.

Similarly, if you prefer starting with hands-on patient care roles, the fastest and easiest lpn programs provide accessible options to enter the nursing workforce with practical skills. These programs are ideal for gaining foundational knowledge pivotal in immunological patient management.

For advanced practice, the easiest np programs to get into can be a practical gateway. Nurse practitioner roles often collaborate with immunologists, especially in specialties like infectious diseases and immunotherapy.

For mental health enthusiasts, online options like the online pmhnp programs with clinical placement combine flexibility with hands-on experience. These programs prepare graduates to support patient immune health through mental wellness, a critical aspect of comprehensive healthcare.

Best Scientists Citing Marc Schmitz

Trending Scientists